$2128.33
-173.55-7.54%
À la fermeture: -
$2139.00
10.670.50%
Après les heures de négociation: 7:33 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
MercadoLibre Inc a un objectif de cours consensus de $2710, basé sur les évaluations des 21 analystes. Le plus élevé est de $3500 attribué par Scotiabank le juillet 28, 2025, et le plus bas est de $1650 attribué par New Street Research le septembre 1, 2023. Les 3 dernières évaluations d'analystes ont été publiées par Morgan Stanley, JP Morgan et Benchmark le novembre 3, 2025, novembre 3, 2025 et octobre 30, 2025. Avec un objectif de cours moyen de $2793.33 entre Morgan Stanley, JP Morgan et Benchmark, il y a une variation implicite de 30.59% upside pour MercadoLibre Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Morgan Stanley
JP Morgan
Benchmark
Barclays
Cantor Fitzgerald
1calculé à partir des notes des analystes
Notes d'analystes pour MercadoLibre
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 37.91% | Morgan Stanley | $2850 → $2950 | Maintains | Overweight | |||
11/03/2025 | 23.89% | JP Morgan | $2600 → $2650 | Maintains | Neutral | |||
10/30/2025 | 29.97% | Benchmark | $2875 → $2780 | Maintains | Buy | |||
10/30/2025 | 35.58% | Barclays | $2800 → $2900 | Maintains | Overweight | |||
10/30/2025 | 28.56% | Cantor Fitzgerald | $2900 → $2750 | Maintains | Overweight | |||
10/21/2025 | 34.41% | Benchmark | $2875 → $2875 | Reiterates | Buy → Buy | |||
10/21/2025 | 30.9% | Barclays | $3000 → $2800 | Maintains | Overweight | |||
10/13/2025 | 35.58% | Susquehanna | $2975 → $2900 | Maintains | Positive | |||
10/09/2025 | 26.23% | Citigroup | $2850 → $2700 | Maintains | Buy | |||
10/03/2025 | 21.55% | JP Morgan | $2700 → $2600 | Maintains | Neutral | |||
09/24/2025 | 35.58% | Cantor Fitzgerald | $2700 → $2900 | Maintains | Overweight | |||
08/18/2025 | 33.24% | Citigroup | $2900 → $2850 | Maintains | Buy | |||
08/07/2025 | 26.23% | JP Morgan | $2600 → $2700 | Maintains | Neutral | |||
08/05/2025 | 34.41% | Benchmark | $2875 → $2875 | Reiterates | Buy → Buy | |||
08/05/2025 | 26.23% | Cantor Fitzgerald | $2700 → $2700 | Reiterates | Overweight → Overweight | |||
08/05/2025 | 28.56% | Raymond James | $2750 → $2750 | Reiterates | Strong Buy → Strong Buy | |||
08/05/2025 | 26.23% | Wedbush | $2800 → $2700 | Maintains | Outperform | |||
08/05/2025 | 30.9% | Jefferies | $2800 → $2800 | Maintains | Hold | |||
08/01/2025 | 40.25% | Daiwa Capital | → $3000 | Initiates | → Buy | |||
07/28/2025 | 63.63% | Scotiabank | → $3500 | Initiates | → Sector Outperform | |||
07/23/2025 | 40.25% | Barclays | $3100 → $3000 | Maintains | Overweight | |||
07/17/2025 | 35.58% | Citigroup | $3000 → $2900 | Maintains | Buy | |||
06/26/2025 | 39.08% | Susquehanna | $2840 → $2975 | Maintains | Positive | |||
06/11/2025 | 26.23% | Cantor Fitzgerald | $2900 → $2700 | Maintains | Overweight | |||
06/05/2025 | 30.9% | Jefferies | $2450 → $2800 | Downgrade | Buy → Hold | |||
05/22/2025 | 21.55% | JP Morgan | $2250 → $2600 | Maintains | Neutral | |||
05/14/2025 | 40.25% | Goldman Sachs | $2640 → $3000 | Maintains | Buy | |||
05/08/2025 | 35.58% | Cantor Fitzgerald | $2400 → $2900 | Maintains | Overweight | |||
05/08/2025 | 44.93% | Barclays | $2500 → $3100 | Maintains | Overweight | |||
04/16/2025 | 12.2% | Cantor Fitzgerald | $3000 → $2400 | Maintains | Overweight | |||
04/15/2025 | 16.88% | Benchmark | → $2500 | Initiates | → Buy | |||
04/10/2025 | 19.68% | Morgan Stanley | $2650 → $2560 | Maintains | Overweight | |||
04/07/2025 | 5.19% | JP Morgan | $2300 → $2250 | Maintains | Neutral | |||
03/04/2025 | 14.54% | Jefferies | $2250 → $2450 | Maintains | Buy | |||
03/03/2025 | 28.56% | Goldman Sachs | $2400 → $2750 | Maintains | Buy | |||
02/25/2025 | 7.53% | JP Morgan | $1950 → $2300 | Maintains | Neutral | |||
02/24/2025 | 23.89% | Morgan Stanley | $2400 → $2650 | Maintains | Overweight | |||
02/21/2025 | 40.25% | Cantor Fitzgerald | $2150 → $3000 | Maintains | Overweight | |||
02/21/2025 | 29.03% | Susquehanna | $2350 → $2760 | Maintains | Positive | |||
02/21/2025 | 40.25% | B of A Securities | $2500 → $3000 | Maintains | Buy | |||
02/21/2025 | 16.88% | Barclays | $2200 → $2500 | Maintains | Overweight | |||
01/21/2025 | 5.19% | Raymond James | $2250 → $2250 | Upgrade | Outperform → Strong Buy | |||
01/10/2025 | 12.2% | Morgan Stanley | $2450 → $2400 | Maintains | Overweight | |||
01/08/2025 | -8.84% | JP Morgan | $2150 → $1950 | Maintains | Neutral | |||
01/07/2025 | 0.51% | Cantor Fitzgerald | $2300 → $2150 | Maintains | Overweight | |||
01/06/2025 | -1.82% | Wedbush | $2200 → $2100 | Maintains | Outperform | |||
11/26/2024 | 14.54% | Citigroup | $2480 → $2450 | Maintains | Buy | |||
11/13/2024 | 0.51% | JP Morgan | $2400 → $2150 | Maintains | Neutral | |||
11/12/2024 | 2.85% | Barclays | $2500 → $2200 | Maintains | Overweight | |||
11/11/2024 | 14.54% | Morgan Stanley | $2500 → $2450 | Maintains | Overweight | |||
11/07/2024 | 2.85% | BTIG | $2250 → $2200 | Maintains | Buy | |||
11/07/2024 | 7.53% | Cantor Fitzgerald | $2530 → $2300 | Maintains | Overweight | |||
10/31/2024 | 12.2% | UBS | $2300 → $2400 | Maintains | Buy | |||
10/22/2024 | 15.94% | Citigroup | $2200 → $2480 | Maintains | Buy | |||
10/11/2024 | 30.9% | Redburn Atlantic | → $2800 | Initiates | → Buy | |||
10/02/2024 | 16.88% | Barclays | $2100 → $2500 | Maintains | Overweight | |||
10/02/2024 | 12.2% | JP Morgan | $2400 → $2400 | Downgrade | Overweight → Neutral | |||
09/27/2024 | 9.86% | Raymond James | → $2350 | Initiates | → Outperform | |||
09/23/2024 | 18.28% | Cantor Fitzgerald | $2530 → $2530 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 16.88% | Morgan Stanley | $2175 → $2500 | Maintains | Overweight | |||
09/12/2024 | 16.88% | B of A Securities | $2250 → $2500 | Maintains | Buy | |||
09/05/2024 | 18.28% | Cantor Fitzgerald | → $2530 | Initiates | → Overweight | |||
08/28/2024 | 9.86% | Susquehanna | $2300 → $2350 | Maintains | Positive | |||
08/27/2024 | 5.19% | Jefferies | $2100 → $2250 | Maintains | Buy | |||
08/23/2024 | 7.53% | UBS | $2000 → $2300 | Maintains | Buy | |||
08/21/2024 | 5.19% | BTIG | $2025 → $2250 | Maintains | Buy | |||
08/19/2024 | 7.53% | Susquehanna | $2000 → $2300 | Maintains | Positive | |||
08/15/2024 | 2.85% | Citigroup | $2000 → $2200 | Maintains | Buy | |||
08/08/2024 | 15.94% | Goldman Sachs | $2180 → $2480 | Maintains | Buy | |||
08/06/2024 | 12.2% | JP Morgan | $2150 → $2400 | Maintains | Overweight | |||
08/06/2024 | -1.82% | Barclays | $2000 → $2100 | Maintains | Overweight | |||
08/02/2024 | -5.33% | BTIG | $1885 → $2025 | Maintains | Buy | |||
07/19/2024 | -6.5% | UBS | $1950 → $2000 | Maintains | Buy | |||
06/07/2024 | -8.84% | UBS | $1800 → $1950 | Maintains | Buy | |||
05/20/2024 | -1.82% | Jefferies | → $2100 | Upgrade | Hold → Buy | |||
05/13/2024 | -6.5% | Barclays | $1800 → $2000 | Maintains | Overweight | |||
05/03/2024 | -15.85% | Wedbush | $1800 → $1800 | Reiterates | Outperform → Outperform | |||
04/24/2024 | -15.85% | Wedbush | $2000 → $1800 | Maintains | Outperform | |||
04/17/2024 | -15.85% | UBS | $1900 → $1800 | Maintains | Buy | |||
04/03/2024 | -15.85% | Barclays | $2000 → $1800 | Maintains | Overweight | |||
03/27/2024 | -9.3% | Citigroup | $1990 → $1940 | Maintains | Buy | |||
03/06/2024 | -6.5% | Wedbush | $2000 → $2000 | Reiterates | Outperform → Outperform | |||
03/05/2024 | -6.5% | Wedbush | $2000 → $2000 | Reiterates | Outperform → Outperform | |||
02/27/2024 | 0.51% | JP Morgan | $2000 → $2150 | Maintains | Overweight | |||
02/23/2024 | -6.5% | Barclays | $1900 → $2000 | Maintains | Overweight | |||
02/23/2024 | -6.5% | Susquehanna | $1850 → $2000 | Maintains | Positive | |||
02/23/2024 | -6.5% | Wedbush | $1800 → $2000 | Maintains | Outperform | |||
01/03/2024 | -11.17% | Citigroup | $1550 → $1900 | Maintains | Buy | |||
12/27/2023 | -15.85% | Wedbush | $1700 → $1800 | Maintains | Outperform | |||
11/28/2023 | -13.51% | Susquehanna | $1625 → $1850 | Maintains | Positive | |||
11/02/2023 | -29.87% | Wedbush | → $1500 | Reiterates | Outperform → Outperform | |||
09/18/2023 | -24.03% | Susquehanna | $1500 → $1625 | Maintains | Positive | |||
09/01/2023 | -22.86% | New Street Research | → $1650 | Upgrade | Neutral → Buy | |||
08/30/2023 | -20.52% | UBS | $1600 → $1700 | Maintains | Buy | |||
08/22/2023 | -29.87% | Wedbush | → $1500 | Initiates | → Outperform | |||
08/09/2023 | 1.92% | Goldman Sachs | $1910 → $2180 | Maintains | Buy | |||
08/08/2023 | -24.03% | Barclays | $1575 → $1625 | Maintains | Overweight | |||
08/07/2023 | -6.5% | JP Morgan | $1700 → $2000 | Maintains | Overweight | |||
08/03/2023 | -16.78% | Credit Suisse | $1760 → $1780 | Maintains | Outperform | |||
07/31/2023 | -17.72% | Credit Suisse | $1730 → $1760 | Maintains | Outperform |
FAQ
Quel est le cours indicatif de l'action MercadoLibre (MELI) ?
Le dernier objectif de prix pour MercadoLibre (NASDAQ:MELI) a été rapporté par Morgan Stanley le novembre 3, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $2950.00 s'attendant à ce que MELI se rise dans les 12 prochains mois (un possible changement de 37.91% upside). 50 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour MercadoLibre (MELI) ?
La dernière note d'analyste pour MercadoLibre (NASDAQ:MELI) a été fournie par Morgan Stanley, et MercadoLibre maintenu leur note overweight.
Quand a eu lieu la dernière mise à niveau pour MercadoLibre (MELI) ?
La dernière amélioration pour MercadoLibre Inc a eu lieu le janvier 21, 2025 lorsque Raymond James a augmenté leur objectif de prix à $2250. Raymond James avait précédemment an outperform pour MercadoLibre Inc.
Quand a eu lieu la dernière dégradation pour MercadoLibre (MELI) ?
La dernière réduction pour MercadoLibre Inc a eu lieu le juin 5, 2025 lorsque Jefferies a changé leur objectif de prix de $2450 à $2800 pour MercadoLibre Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour MercadoLibre (MELI) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de MercadoLibre, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour MercadoLibre a été déposée le novembre 3, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 3, 2026.
La note d'analyste pour MercadoLibre (MELI) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de MercadoLibre (MELI) était un maintenu avec un objectif de prix de $2850.00 à $2950.00. Le prix actuel de MercadoLibre (MELI) est de $2139.00, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.